Skip to content
MedsAcross

Medicine

Zoledronic acid 5 mg/100 mL injection

Zoledronic acid · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Zoledronic acid 5 mg/100 mL injection is a generic prescription medicine for intravenous use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Key facts

Active ingredient (INN)
Zoledronic acid
Brand
Sold under the generic name
Strength
5 mg/100 mL
Dosage form
Injection
Route
Intravenous
Packs
100 mL, 1 vial of 100 mL, 1 bag of 100 mL and 10 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaGland PharmaIndiaEugiaIndiaMylan InstitutionalSagent PharmaceuticalsBluePoint LaboratoriesFosun PharmaFresenius KabiMeitheal Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
M05BA08 Zoledronic acid
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 March 2013
Identifiers
RxCUI 705824DailyMed set ID fd0324d8-b9bd-fd4c-e053-6394a90a5465, 5de65a7f-a219-4b22-9155-61fedc84433b, f94a5c9e-74bc-d09e-cd65-394b2a5de2ad +9NDC 72266-152, 68001-611, 55111-688 +9Application ANDA209578, ANDA091363, ANDA209125 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 mL in 1 bottle, glass43598-331-11Dr. Reddy's LaboratoriesIndia19 August 2013
100 mL in 1 bottle, glass55111-688-52Dr. Reddy's LaboratoriesIndia3 April 2013
1 vial, glass in 1 carton / 100 mL in 1 vial, glass68083-135-01Gland PharmaIndia15 September 2016
1 bag in 1 carton / 100 mL in 1 bag68083-256-01Gland PharmaIndia13 March 2017
1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass55150-283-99EugiaIndia8 December 2017
1 vial in 1 carton / 100 mL in 1 vial67457-619-10Mylan Institutional19 May 2017
1 bag in 1 pouch / 100 mL in 1 bag67457-794-10Mylan Institutional5 June 2018
1 bag in 1 carton / 100 mL in 1 bag72266-152-01Fosun Pharma12 June 2023
1 vial, glass in 1 carton / 100 mL in 1 vial, glass63323-966-00Fresenius Kabi17 February 2017
1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass71288-806-51Meitheal Pharmaceuticals5 June 2023
1 bag in 1 carton / 100 mL in 1 bag25021-830-82Sagent Pharmaceuticals2 March 2013
5 bag in 1 carton / 100 mL in 1 bag25021-830-87Sagent Pharmaceuticals15 April 2025
1 bag in 1 carton / 100 mL in 1 bag68001-611-33BluePoint Laboratories6 July 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 August 2001Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Zoledronic acid 5 mg/100 mL injection.

Compare 1

Other strengths and forms of Zoledronic acid

Clinical summary

Zoledronic acid is a bisphosphonate indicated for treatment and prevention of postmenopausal osteoporosis, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Zoledronic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Zoledronic acid

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Zoledronic acid 5 mg/100 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.